Article Details
Retrieved on: 2021-07-02 11:59:52
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... for Parkinson's Disease and Alzheimer's through a deal with US-listed Alector's (NASDAQ:ALEC) for its monoclonal antibodies AL001 and AL101.
Article found on: www.proactiveinvestors.co.uk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here